nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—CYP3A4—Rivastigmine—Alzheimer's disease	0.189	0.432	CbGbCtD
Levobupivacaine—CYP3A4—Donepezil—Alzheimer's disease	0.151	0.345	CbGbCtD
Levobupivacaine—CYP3A4—Galantamine—Alzheimer's disease	0.0974	0.223	CbGbCtD
Levobupivacaine—SCN4A—L1CAM interactions—DPYSL2—Alzheimer's disease	0.00139	0.0346	CbGpPWpGaD
Levobupivacaine—Ranolazine—CYP2D6—Alzheimer's disease	0.00138	0.299	CrCbGaD
Levobupivacaine—Bupivacaine—CYP2D6—Alzheimer's disease	0.00135	0.293	CrCbGaD
Levobupivacaine—SCN10A—L1CAM interactions—DPYSL2—Alzheimer's disease	0.00134	0.0333	CbGpPWpGaD
Levobupivacaine—Flushing—Galantamine—Alzheimer's disease	0.00129	0.00249	CcSEcCtD
Levobupivacaine—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.00127	0.00246	CcSEcCtD
Levobupivacaine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00126	0.00244	CcSEcCtD
Levobupivacaine—Muscular weakness—Memantine—Alzheimer's disease	0.00125	0.00241	CcSEcCtD
Levobupivacaine—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.00125	0.00241	CcSEcCtD
Levobupivacaine—Arrhythmia—Galantamine—Alzheimer's disease	0.00124	0.0024	CcSEcCtD
Levobupivacaine—Dysphagia—Memantine—Alzheimer's disease	0.00122	0.00236	CcSEcCtD
Levobupivacaine—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00122	0.00236	CcSEcCtD
Levobupivacaine—Mental disorder—Galantamine—Alzheimer's disease	0.00122	0.00235	CcSEcCtD
Levobupivacaine—Malnutrition—Galantamine—Alzheimer's disease	0.00121	0.00234	CcSEcCtD
Levobupivacaine—Bronchospasm—Memantine—Alzheimer's disease	0.0012	0.00232	CcSEcCtD
Levobupivacaine—Infestation NOS—Donepezil—Alzheimer's disease	0.0012	0.00232	CcSEcCtD
Levobupivacaine—Infestation—Donepezil—Alzheimer's disease	0.0012	0.00232	CcSEcCtD
Levobupivacaine—Dysphagia—Rivastigmine—Alzheimer's disease	0.0012	0.00231	CcSEcCtD
Levobupivacaine—Flatulence—Galantamine—Alzheimer's disease	0.00119	0.0023	CcSEcCtD
Levobupivacaine—Sweating increased—Memantine—Alzheimer's disease	0.00119	0.0023	CcSEcCtD
Levobupivacaine—Tension—Galantamine—Alzheimer's disease	0.00119	0.0023	CcSEcCtD
Levobupivacaine—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00118	0.00227	CcSEcCtD
Levobupivacaine—Nervousness—Galantamine—Alzheimer's disease	0.00118	0.00227	CcSEcCtD
Levobupivacaine—Back pain—Galantamine—Alzheimer's disease	0.00117	0.00226	CcSEcCtD
Levobupivacaine—Urinary tract infection—Donepezil—Alzheimer's disease	0.00117	0.00225	CcSEcCtD
Levobupivacaine—Sweating increased—Rivastigmine—Alzheimer's disease	0.00117	0.00225	CcSEcCtD
Levobupivacaine—Muscle spasms—Galantamine—Alzheimer's disease	0.00116	0.00225	CcSEcCtD
Levobupivacaine—Sweating—Donepezil—Alzheimer's disease	0.00115	0.00222	CcSEcCtD
Levobupivacaine—Haematuria—Donepezil—Alzheimer's disease	0.00115	0.00221	CcSEcCtD
Levobupivacaine—Vision blurred—Galantamine—Alzheimer's disease	0.00114	0.0022	CcSEcCtD
Levobupivacaine—Tremor—Galantamine—Alzheimer's disease	0.00113	0.00219	CcSEcCtD
Levobupivacaine—Anaemia—Galantamine—Alzheimer's disease	0.00112	0.00216	CcSEcCtD
Levobupivacaine—Agitation—Galantamine—Alzheimer's disease	0.00111	0.00215	CcSEcCtD
Levobupivacaine—Bradycardia—Donepezil—Alzheimer's disease	0.0011	0.00212	CcSEcCtD
Levobupivacaine—Infestation NOS—Memantine—Alzheimer's disease	0.00109	0.00211	CcSEcCtD
Levobupivacaine—Infestation—Memantine—Alzheimer's disease	0.00109	0.00211	CcSEcCtD
Levobupivacaine—Ropivacaine—CYP2D6—Alzheimer's disease	0.00109	0.236	CrCbGaD
Levobupivacaine—Syncope—Galantamine—Alzheimer's disease	0.00109	0.0021	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00107	0.00207	CcSEcCtD
Levobupivacaine—Palpitations—Galantamine—Alzheimer's disease	0.00107	0.00207	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00107	0.00206	CcSEcCtD
Levobupivacaine—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00107	0.00206	CcSEcCtD
Levobupivacaine—Infestation—Rivastigmine—Alzheimer's disease	0.00107	0.00206	CcSEcCtD
Levobupivacaine—Drowsiness—Rivastigmine—Alzheimer's disease	0.00107	0.00206	CcSEcCtD
Levobupivacaine—Loss of consciousness—Galantamine—Alzheimer's disease	0.00106	0.00206	CcSEcCtD
Levobupivacaine—Oedema peripheral—Donepezil—Alzheimer's disease	0.00106	0.00205	CcSEcCtD
Levobupivacaine—Urinary tract infection—Memantine—Alzheimer's disease	0.00106	0.00205	CcSEcCtD
Levobupivacaine—Cough—Galantamine—Alzheimer's disease	0.00106	0.00204	CcSEcCtD
Levobupivacaine—Convulsion—Galantamine—Alzheimer's disease	0.00105	0.00203	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.00105	0.00202	CcSEcCtD
Levobupivacaine—Hypertension—Galantamine—Alzheimer's disease	0.00105	0.00202	CcSEcCtD
Levobupivacaine—Haematuria—Memantine—Alzheimer's disease	0.00104	0.00201	CcSEcCtD
Levobupivacaine—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00104	0.002	CcSEcCtD
Levobupivacaine—Arthralgia—Galantamine—Alzheimer's disease	0.00103	0.00199	CcSEcCtD
Levobupivacaine—Anxiety—Galantamine—Alzheimer's disease	0.00103	0.00198	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00102	0.00198	CcSEcCtD
Levobupivacaine—Sweating—Rivastigmine—Alzheimer's disease	0.00102	0.00198	CcSEcCtD
Levobupivacaine—Haematuria—Rivastigmine—Alzheimer's disease	0.00102	0.00196	CcSEcCtD
Levobupivacaine—Tinnitus—Donepezil—Alzheimer's disease	0.00101	0.00194	CcSEcCtD
Levobupivacaine—Confusional state—Galantamine—Alzheimer's disease	0.000997	0.00192	CcSEcCtD
Levobupivacaine—Bradycardia—Memantine—Alzheimer's disease	0.000997	0.00192	CcSEcCtD
Levobupivacaine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000975	0.00188	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000974	0.00188	CcSEcCtD
Levobupivacaine—Shock—Galantamine—Alzheimer's disease	0.000972	0.00188	CcSEcCtD
Levobupivacaine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000969	0.00187	CcSEcCtD
Levobupivacaine—Chills—Donepezil—Alzheimer's disease	0.000967	0.00187	CcSEcCtD
Levobupivacaine—Tachycardia—Galantamine—Alzheimer's disease	0.000965	0.00186	CcSEcCtD
Levobupivacaine—Oedema peripheral—Memantine—Alzheimer's disease	0.000964	0.00186	CcSEcCtD
Levobupivacaine—Arrhythmia—Donepezil—Alzheimer's disease	0.000963	0.00186	CcSEcCtD
Levobupivacaine—Skin disorder—Galantamine—Alzheimer's disease	0.00096	0.00185	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000955	0.00185	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000953	0.00184	CcSEcCtD
Levobupivacaine—Mental disorder—Donepezil—Alzheimer's disease	0.000945	0.00182	CcSEcCtD
Levobupivacaine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000943	0.00182	CcSEcCtD
Levobupivacaine—Erythema—Donepezil—Alzheimer's disease	0.000938	0.00181	CcSEcCtD
Levobupivacaine—Malnutrition—Donepezil—Alzheimer's disease	0.000938	0.00181	CcSEcCtD
Levobupivacaine—Flatulence—Donepezil—Alzheimer's disease	0.000925	0.00179	CcSEcCtD
Levobupivacaine—Hypotension—Galantamine—Alzheimer's disease	0.000924	0.00178	CcSEcCtD
Levobupivacaine—Tension—Donepezil—Alzheimer's disease	0.000921	0.00178	CcSEcCtD
Levobupivacaine—Tinnitus—Memantine—Alzheimer's disease	0.000913	0.00176	CcSEcCtD
Levobupivacaine—Nervousness—Donepezil—Alzheimer's disease	0.000912	0.00176	CcSEcCtD
Levobupivacaine—Flushing—Memantine—Alzheimer's disease	0.000908	0.00175	CcSEcCtD
Levobupivacaine—Cardiac disorder—Memantine—Alzheimer's disease	0.000908	0.00175	CcSEcCtD
Levobupivacaine—Back pain—Donepezil—Alzheimer's disease	0.000908	0.00175	CcSEcCtD
Levobupivacaine—Muscle spasms—Donepezil—Alzheimer's disease	0.000902	0.00174	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.0009	0.00174	CcSEcCtD
Levobupivacaine—Insomnia—Galantamine—Alzheimer's disease	0.000894	0.00173	CcSEcCtD
Levobupivacaine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000893	0.00172	CcSEcCtD
Levobupivacaine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000889	0.00172	CcSEcCtD
Levobupivacaine—Flushing—Rivastigmine—Alzheimer's disease	0.000889	0.00172	CcSEcCtD
Levobupivacaine—Paraesthesia—Galantamine—Alzheimer's disease	0.000887	0.00171	CcSEcCtD
Levobupivacaine—Vision blurred—Donepezil—Alzheimer's disease	0.000884	0.00171	CcSEcCtD
Levobupivacaine—Tremor—Donepezil—Alzheimer's disease	0.000879	0.0017	CcSEcCtD
Levobupivacaine—Somnolence—Galantamine—Alzheimer's disease	0.000879	0.0017	CcSEcCtD
Levobupivacaine—Chills—Memantine—Alzheimer's disease	0.000878	0.0017	CcSEcCtD
Levobupivacaine—Arrhythmia—Memantine—Alzheimer's disease	0.000874	0.00169	CcSEcCtD
Levobupivacaine—Dyspepsia—Galantamine—Alzheimer's disease	0.00087	0.00168	CcSEcCtD
Levobupivacaine—Anaemia—Donepezil—Alzheimer's disease	0.000867	0.00168	CcSEcCtD
Levobupivacaine—Agitation—Donepezil—Alzheimer's disease	0.000862	0.00167	CcSEcCtD
Levobupivacaine—Chills—Rivastigmine—Alzheimer's disease	0.000859	0.00166	CcSEcCtD
Levobupivacaine—Decreased appetite—Galantamine—Alzheimer's disease	0.000859	0.00166	CcSEcCtD
Levobupivacaine—Mental disorder—Memantine—Alzheimer's disease	0.000858	0.00166	CcSEcCtD
Levobupivacaine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000855	0.00165	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000853	0.00165	CcSEcCtD
Levobupivacaine—Malnutrition—Memantine—Alzheimer's disease	0.000852	0.00165	CcSEcCtD
Levobupivacaine—Constipation—Galantamine—Alzheimer's disease	0.000845	0.00163	CcSEcCtD
Levobupivacaine—Syncope—Donepezil—Alzheimer's disease	0.000842	0.00163	CcSEcCtD
Levobupivacaine—Flatulence—Memantine—Alzheimer's disease	0.00084	0.00162	CcSEcCtD
Levobupivacaine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000839	0.00162	CcSEcCtD
Levobupivacaine—Tension—Memantine—Alzheimer's disease	0.000836	0.00162	CcSEcCtD
Levobupivacaine—Erythema—Rivastigmine—Alzheimer's disease	0.000834	0.00161	CcSEcCtD
Levobupivacaine—Malnutrition—Rivastigmine—Alzheimer's disease	0.000834	0.00161	CcSEcCtD
Levobupivacaine—Nervousness—Memantine—Alzheimer's disease	0.000828	0.0016	CcSEcCtD
Levobupivacaine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000825	0.00159	CcSEcCtD
Levobupivacaine—Back pain—Memantine—Alzheimer's disease	0.000824	0.00159	CcSEcCtD
Levobupivacaine—Flatulence—Rivastigmine—Alzheimer's disease	0.000821	0.00159	CcSEcCtD
Levobupivacaine—Cough—Donepezil—Alzheimer's disease	0.000819	0.00158	CcSEcCtD
Levobupivacaine—Tension—Rivastigmine—Alzheimer's disease	0.000818	0.00158	CcSEcCtD
Levobupivacaine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000814	0.00157	CcSEcCtD
Levobupivacaine—Convulsion—Donepezil—Alzheimer's disease	0.000813	0.00157	CcSEcCtD
Levobupivacaine—Hypertension—Donepezil—Alzheimer's disease	0.00081	0.00157	CcSEcCtD
Levobupivacaine—Nervousness—Rivastigmine—Alzheimer's disease	0.00081	0.00156	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000808	0.00156	CcSEcCtD
Levobupivacaine—Back pain—Rivastigmine—Alzheimer's disease	0.000806	0.00156	CcSEcCtD
Levobupivacaine—Vision blurred—Memantine—Alzheimer's disease	0.000803	0.00155	CcSEcCtD
Levobupivacaine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000801	0.00155	CcSEcCtD
Levobupivacaine—Arthralgia—Donepezil—Alzheimer's disease	0.000799	0.00154	CcSEcCtD
Levobupivacaine—Tremor—Memantine—Alzheimer's disease	0.000798	0.00154	CcSEcCtD
Levobupivacaine—Anxiety—Donepezil—Alzheimer's disease	0.000796	0.00154	CcSEcCtD
Levobupivacaine—Lidocaine—CYP2D6—Alzheimer's disease	0.000792	0.172	CrCbGaD
Levobupivacaine—Anaemia—Memantine—Alzheimer's disease	0.000788	0.00152	CcSEcCtD
Levobupivacaine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000786	0.00152	CcSEcCtD
Levobupivacaine—Agitation—Memantine—Alzheimer's disease	0.000783	0.00151	CcSEcCtD
Levobupivacaine—Abdominal pain—Galantamine—Alzheimer's disease	0.000781	0.00151	CcSEcCtD
Levobupivacaine—Body temperature increased—Galantamine—Alzheimer's disease	0.000781	0.00151	CcSEcCtD
Levobupivacaine—Tremor—Rivastigmine—Alzheimer's disease	0.000781	0.00151	CcSEcCtD
Levobupivacaine—Confusional state—Donepezil—Alzheimer's disease	0.000772	0.00149	CcSEcCtD
Levobupivacaine—Anaemia—Rivastigmine—Alzheimer's disease	0.00077	0.00149	CcSEcCtD
Levobupivacaine—Agitation—Rivastigmine—Alzheimer's disease	0.000766	0.00148	CcSEcCtD
Levobupivacaine—Oedema—Donepezil—Alzheimer's disease	0.000766	0.00148	CcSEcCtD
Levobupivacaine—Syncope—Memantine—Alzheimer's disease	0.000764	0.00148	CcSEcCtD
Levobupivacaine—Infection—Donepezil—Alzheimer's disease	0.000761	0.00147	CcSEcCtD
Levobupivacaine—Shock—Donepezil—Alzheimer's disease	0.000754	0.00146	CcSEcCtD
Levobupivacaine—Palpitations—Memantine—Alzheimer's disease	0.000753	0.00145	CcSEcCtD
Levobupivacaine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000751	0.00145	CcSEcCtD
Levobupivacaine—Loss of consciousness—Memantine—Alzheimer's disease	0.000749	0.00145	CcSEcCtD
Levobupivacaine—Syncope—Rivastigmine—Alzheimer's disease	0.000748	0.00144	CcSEcCtD
Levobupivacaine—Cough—Memantine—Alzheimer's disease	0.000744	0.00144	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00074	0.00143	CcSEcCtD
Levobupivacaine—CYP1A2—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.00074	0.0184	CbGpPWpGaD
Levobupivacaine—Convulsion—Memantine—Alzheimer's disease	0.000738	0.00143	CcSEcCtD
Levobupivacaine—Palpitations—Rivastigmine—Alzheimer's disease	0.000737	0.00142	CcSEcCtD
Levobupivacaine—Hypertension—Memantine—Alzheimer's disease	0.000736	0.00142	CcSEcCtD
Levobupivacaine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000733	0.00142	CcSEcCtD
Levobupivacaine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000728	0.00141	CcSEcCtD
Levobupivacaine—Cough—Rivastigmine—Alzheimer's disease	0.000727	0.00141	CcSEcCtD
Levobupivacaine—Arthralgia—Memantine—Alzheimer's disease	0.000725	0.0014	CcSEcCtD
Levobupivacaine—Anxiety—Memantine—Alzheimer's disease	0.000723	0.0014	CcSEcCtD
Levobupivacaine—Convulsion—Rivastigmine—Alzheimer's disease	0.000722	0.0014	CcSEcCtD
Levobupivacaine—Hypertension—Rivastigmine—Alzheimer's disease	0.00072	0.00139	CcSEcCtD
Levobupivacaine—Hypotension—Donepezil—Alzheimer's disease	0.000716	0.00138	CcSEcCtD
Levobupivacaine—Arthralgia—Rivastigmine—Alzheimer's disease	0.00071	0.00137	CcSEcCtD
Levobupivacaine—Asthenia—Galantamine—Alzheimer's disease	0.000709	0.00137	CcSEcCtD
Levobupivacaine—Anxiety—Rivastigmine—Alzheimer's disease	0.000707	0.00137	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000705	0.00136	CcSEcCtD
Levobupivacaine—Confusional state—Memantine—Alzheimer's disease	0.000701	0.00135	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000698	0.00135	CcSEcCtD
Levobupivacaine—Oedema—Memantine—Alzheimer's disease	0.000695	0.00134	CcSEcCtD
Levobupivacaine—Insomnia—Donepezil—Alzheimer's disease	0.000693	0.00134	CcSEcCtD
Levobupivacaine—Infection—Memantine—Alzheimer's disease	0.000691	0.00133	CcSEcCtD
Levobupivacaine—Paraesthesia—Donepezil—Alzheimer's disease	0.000688	0.00133	CcSEcCtD
Levobupivacaine—Confusional state—Rivastigmine—Alzheimer's disease	0.000686	0.00133	CcSEcCtD
Levobupivacaine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.000685	0.017	CbGpPWpGaD
Levobupivacaine—Shock—Memantine—Alzheimer's disease	0.000684	0.00132	CcSEcCtD
Levobupivacaine—Dyspnoea—Donepezil—Alzheimer's disease	0.000683	0.00132	CcSEcCtD
Levobupivacaine—Nervous system disorder—Memantine—Alzheimer's disease	0.000682	0.00132	CcSEcCtD
Levobupivacaine—Somnolence—Donepezil—Alzheimer's disease	0.000681	0.00132	CcSEcCtD
Levobupivacaine—Oedema—Rivastigmine—Alzheimer's disease	0.00068	0.00131	CcSEcCtD
Levobupivacaine—Tachycardia—Memantine—Alzheimer's disease	0.000679	0.00131	CcSEcCtD
Levobupivacaine—Diarrhoea—Galantamine—Alzheimer's disease	0.000676	0.00131	CcSEcCtD
Levobupivacaine—Infection—Rivastigmine—Alzheimer's disease	0.000676	0.00131	CcSEcCtD
Levobupivacaine—Skin disorder—Memantine—Alzheimer's disease	0.000676	0.0013	CcSEcCtD
Levobupivacaine—Dyspepsia—Donepezil—Alzheimer's disease	0.000674	0.0013	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000672	0.0013	CcSEcCtD
Levobupivacaine—Shock—Rivastigmine—Alzheimer's disease	0.000669	0.00129	CcSEcCtD
Levobupivacaine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000667	0.00129	CcSEcCtD
Levobupivacaine—Decreased appetite—Donepezil—Alzheimer's disease	0.000666	0.00129	CcSEcCtD
Levobupivacaine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000664	0.00128	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000661	0.00128	CcSEcCtD
Levobupivacaine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000661	0.00128	CcSEcCtD
Levobupivacaine—SCN4A—Axon guidance—TREM2—Alzheimer's disease	0.000658	0.0163	CbGpPWpGaD
Levobupivacaine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000658	0.00127	CcSEcCtD
Levobupivacaine—Pain—Donepezil—Alzheimer's disease	0.000655	0.00127	CcSEcCtD
Levobupivacaine—Constipation—Donepezil—Alzheimer's disease	0.000655	0.00127	CcSEcCtD
Levobupivacaine—Dizziness—Galantamine—Alzheimer's disease	0.000654	0.00126	CcSEcCtD
Levobupivacaine—Hypotension—Memantine—Alzheimer's disease	0.00065	0.00126	CcSEcCtD
Levobupivacaine—Hypotension—Rivastigmine—Alzheimer's disease	0.000636	0.00123	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—TREM2—Alzheimer's disease	0.000635	0.0158	CbGpPWpGaD
Levobupivacaine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000634	0.00122	CcSEcCtD
Levobupivacaine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000631	0.00122	CcSEcCtD
Levobupivacaine—SCN4A—L1CAM interactions—DLG4—Alzheimer's disease	0.000629	0.0156	CbGpPWpGaD
Levobupivacaine—Insomnia—Memantine—Alzheimer's disease	0.000629	0.00121	CcSEcCtD
Levobupivacaine—Vomiting—Galantamine—Alzheimer's disease	0.000628	0.00121	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000626	0.00121	CcSEcCtD
Levobupivacaine—Paraesthesia—Memantine—Alzheimer's disease	0.000624	0.00121	CcSEcCtD
Levobupivacaine—Dyspnoea—Memantine—Alzheimer's disease	0.00062	0.0012	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00062	0.0012	CcSEcCtD
Levobupivacaine—Headache—Galantamine—Alzheimer's disease	0.000619	0.0012	CcSEcCtD
Levobupivacaine—Somnolence—Memantine—Alzheimer's disease	0.000618	0.00119	CcSEcCtD
Levobupivacaine—Insomnia—Rivastigmine—Alzheimer's disease	0.000615	0.00119	CcSEcCtD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—MAP2—Alzheimer's disease	0.000615	0.0153	CbGpPWpGaD
Levobupivacaine—Dyspepsia—Memantine—Alzheimer's disease	0.000612	0.00118	CcSEcCtD
Levobupivacaine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000611	0.00118	CcSEcCtD
Levobupivacaine—Urticaria—Donepezil—Alzheimer's disease	0.000608	0.00118	CcSEcCtD
Levobupivacaine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000607	0.00117	CcSEcCtD
Levobupivacaine—SCN10A—L1CAM interactions—DLG4—Alzheimer's disease	0.000607	0.0151	CbGpPWpGaD
Levobupivacaine—Abdominal pain—Donepezil—Alzheimer's disease	0.000605	0.00117	CcSEcCtD
Levobupivacaine—Body temperature increased—Donepezil—Alzheimer's disease	0.000605	0.00117	CcSEcCtD
Levobupivacaine—Somnolence—Rivastigmine—Alzheimer's disease	0.000605	0.00117	CcSEcCtD
Levobupivacaine—Decreased appetite—Memantine—Alzheimer's disease	0.000605	0.00117	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.0006	0.00116	CcSEcCtD
Levobupivacaine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000599	0.00116	CcSEcCtD
Levobupivacaine—Pain—Memantine—Alzheimer's disease	0.000595	0.00115	CcSEcCtD
Levobupivacaine—Constipation—Memantine—Alzheimer's disease	0.000595	0.00115	CcSEcCtD
Levobupivacaine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000591	0.00114	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000587	0.00113	CcSEcCtD
Levobupivacaine—Nausea—Galantamine—Alzheimer's disease	0.000587	0.00113	CcSEcCtD
Levobupivacaine—Constipation—Rivastigmine—Alzheimer's disease	0.000582	0.00112	CcSEcCtD
Levobupivacaine—Pain—Rivastigmine—Alzheimer's disease	0.000582	0.00112	CcSEcCtD
Levobupivacaine—Feeling abnormal—Memantine—Alzheimer's disease	0.000573	0.00111	CcSEcCtD
Levobupivacaine—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000571	0.0142	CbGpPWpGaD
Levobupivacaine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000569	0.0011	CcSEcCtD
Levobupivacaine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000564	0.00109	CcSEcCtD
Levobupivacaine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000561	0.00108	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000556	0.00107	CcSEcCtD
Levobupivacaine—Urticaria—Memantine—Alzheimer's disease	0.000552	0.00107	CcSEcCtD
Levobupivacaine—Abdominal pain—Memantine—Alzheimer's disease	0.00055	0.00106	CcSEcCtD
Levobupivacaine—Body temperature increased—Memantine—Alzheimer's disease	0.00055	0.00106	CcSEcCtD
Levobupivacaine—Asthenia—Donepezil—Alzheimer's disease	0.00055	0.00106	CcSEcCtD
Levobupivacaine—Pruritus—Donepezil—Alzheimer's disease	0.000542	0.00105	CcSEcCtD
Levobupivacaine—Urticaria—Rivastigmine—Alzheimer's disease	0.00054	0.00104	CcSEcCtD
Levobupivacaine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000538	0.00104	CcSEcCtD
Levobupivacaine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000538	0.00104	CcSEcCtD
Levobupivacaine—SCN4A—Axon guidance—DPYSL2—Alzheimer's disease	0.000526	0.0131	CbGpPWpGaD
Levobupivacaine—Diarrhoea—Donepezil—Alzheimer's disease	0.000524	0.00101	CcSEcCtD
Levobupivacaine—CYP1A2—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000513	0.0127	CbGpPWpGaD
Levobupivacaine—Hypersensitivity—Memantine—Alzheimer's disease	0.000512	0.00099	CcSEcCtD
Levobupivacaine—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.00051	0.0127	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—DPYSL2—Alzheimer's disease	0.000507	0.0126	CbGpPWpGaD
Levobupivacaine—Dizziness—Donepezil—Alzheimer's disease	0.000506	0.000978	CcSEcCtD
Levobupivacaine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000501	0.000968	CcSEcCtD
Levobupivacaine—Asthenia—Memantine—Alzheimer's disease	0.000499	0.000964	CcSEcCtD
Levobupivacaine—SCN4A—Axon guidance—EPHA1—Alzheimer's disease	0.000499	0.0124	CbGpPWpGaD
Levobupivacaine—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.000492	0.0122	CbGpPWpGaD
Levobupivacaine—Pruritus—Memantine—Alzheimer's disease	0.000492	0.00095	CcSEcCtD
Levobupivacaine—Asthenia—Rivastigmine—Alzheimer's disease	0.000488	0.000943	CcSEcCtD
Levobupivacaine—Vomiting—Donepezil—Alzheimer's disease	0.000487	0.000941	CcSEcCtD
Levobupivacaine—Pruritus—Rivastigmine—Alzheimer's disease	0.000481	0.00093	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—EPHA1—Alzheimer's disease	0.000481	0.0119	CbGpPWpGaD
Levobupivacaine—Headache—Donepezil—Alzheimer's disease	0.00048	0.000927	CcSEcCtD
Levobupivacaine—Diarrhoea—Memantine—Alzheimer's disease	0.000476	0.000919	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—TREM2—Alzheimer's disease	0.00047	0.0117	CbGpPWpGaD
Levobupivacaine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000465	0.000899	CcSEcCtD
Levobupivacaine—Dizziness—Memantine—Alzheimer's disease	0.00046	0.000888	CcSEcCtD
Levobupivacaine—SCN4A—Axon guidance—CDK5—Alzheimer's disease	0.000456	0.0113	CbGpPWpGaD
Levobupivacaine—Nausea—Donepezil—Alzheimer's disease	0.000455	0.000879	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—TREM2—Alzheimer's disease	0.000453	0.0112	CbGpPWpGaD
Levobupivacaine—Dizziness—Rivastigmine—Alzheimer's disease	0.00045	0.000869	CcSEcCtD
Levobupivacaine—Vomiting—Memantine—Alzheimer's disease	0.000442	0.000854	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—CDK5—Alzheimer's disease	0.00044	0.0109	CbGpPWpGaD
Levobupivacaine—Headache—Memantine—Alzheimer's disease	0.000436	0.000842	CcSEcCtD
Levobupivacaine—Vomiting—Rivastigmine—Alzheimer's disease	0.000433	0.000836	CcSEcCtD
Levobupivacaine—CYP1A2—Xenobiotics—CYP2D6—Alzheimer's disease	0.000426	0.0106	CbGpPWpGaD
Levobupivacaine—Headache—Rivastigmine—Alzheimer's disease	0.000426	0.000823	CcSEcCtD
Levobupivacaine—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000415	0.0103	CbGpPWpGaD
Levobupivacaine—Nausea—Memantine—Alzheimer's disease	0.000413	0.000798	CcSEcCtD
Levobupivacaine—CYP1A2—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.00041	0.0102	CbGpPWpGaD
Levobupivacaine—Nausea—Rivastigmine—Alzheimer's disease	0.000404	0.000781	CcSEcCtD
Levobupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000399	0.00992	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—PSENEN—Alzheimer's disease	0.000399	0.00991	CbGpPWpGaD
Levobupivacaine—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000396	0.00984	CbGpPWpGaD
Levobupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000394	0.00979	CbGpPWpGaD
Levobupivacaine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000393	0.00978	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—APH1A—Alzheimer's disease	0.000393	0.00977	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—PSENEN—Alzheimer's disease	0.000384	0.00955	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—NCSTN—Alzheimer's disease	0.000383	0.00951	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—APH1A—Alzheimer's disease	0.000379	0.00942	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—DPYSL2—Alzheimer's disease	0.000375	0.00933	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—NCSTN—Alzheimer's disease	0.000369	0.00917	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—DPYSL2—Alzheimer's disease	0.000362	0.00899	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—EPHA1—Alzheimer's disease	0.000356	0.00884	CbGpPWpGaD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—ACHE—Alzheimer's disease	0.000345	0.00856	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—EPHA1—Alzheimer's disease	0.000343	0.00853	CbGpPWpGaD
Levobupivacaine—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000329	0.00818	CbGpPWpGaD
Levobupivacaine—CYP1A2—Estrogen Receptor Pathway—ESR1—Alzheimer's disease	0.000328	0.00814	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—CDK5—Alzheimer's disease	0.000325	0.00809	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000324	0.00804	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—PRNP—Alzheimer's disease	0.000321	0.00798	CbGpPWpGaD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—CYP2D6—Alzheimer's disease	0.000317	0.00787	CbGpPWpGaD
Levobupivacaine—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000317	0.00786	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—CDK5—Alzheimer's disease	0.000314	0.0078	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—PSEN2—Alzheimer's disease	0.000311	0.00773	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—PRNP—Alzheimer's disease	0.00031	0.0077	CbGpPWpGaD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000308	0.00766	CbGpPWpGaD
Levobupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000304	0.00756	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—PSEN2—Alzheimer's disease	0.0003	0.00746	CbGpPWpGaD
Levobupivacaine—CYP1A2—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000295	0.00732	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—PSENEN—Alzheimer's disease	0.000284	0.00707	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—APH1A—Alzheimer's disease	0.000281	0.00697	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—PSENEN—Alzheimer's disease	0.000274	0.00682	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—NCSTN—Alzheimer's disease	0.000273	0.00679	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—APH1A—Alzheimer's disease	0.000271	0.00672	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—NCSTN—Alzheimer's disease	0.000263	0.00654	CbGpPWpGaD
Levobupivacaine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000256	0.00637	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.00025	0.00621	CbGpPWpGaD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000242	0.00601	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—DLG4—Alzheimer's disease	0.000238	0.00591	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—GRIN2B—Alzheimer's disease	0.000232	0.00577	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—PRNP—Alzheimer's disease	0.000229	0.0057	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—DLG4—Alzheimer's disease	0.000229	0.00569	CbGpPWpGaD
Levobupivacaine—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000227	0.00565	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—GRIN2B—Alzheimer's disease	0.000224	0.00557	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—PSEN2—Alzheimer's disease	0.000222	0.00552	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—PRNP—Alzheimer's disease	0.000221	0.00549	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—PSEN2—Alzheimer's disease	0.000214	0.00532	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—ADAM10—Alzheimer's disease	0.000209	0.0052	CbGpPWpGaD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000209	0.00519	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—IAPP—Alzheimer's disease	0.000203	0.00505	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—ADAM10—Alzheimer's disease	0.000202	0.00502	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—IAPP—Alzheimer's disease	0.000196	0.00487	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000193	0.0048	CbGpPWpGaD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000187	0.00464	CbGpPWpGaD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—CALM1—Alzheimer's disease	0.000181	0.0045	CbGpPWpGaD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—APOE—Alzheimer's disease	0.000181	0.00449	CbGpPWpGaD
Levobupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000177	0.0044	CbGpPWpGaD
Levobupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000175	0.00434	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—CYP46A1—Alzheimer's disease	0.000172	0.00427	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—DLG4—Alzheimer's disease	0.00017	0.00421	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.00017	0.00421	CbGpPWpGaD
Levobupivacaine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000169	0.0042	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—GRIN2B—Alzheimer's disease	0.000166	0.00412	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—DLG4—Alzheimer's disease	0.000164	0.00406	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—GRIN2B—Alzheimer's disease	0.00016	0.00397	CbGpPWpGaD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	0.000156	0.00389	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—ADAM10—Alzheimer's disease	0.000149	0.00371	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000149	0.0037	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—LPL—Alzheimer's disease	0.000149	0.0037	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—Alzheimer's disease	0.000148	0.00368	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000146	0.00364	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—ADAM10—Alzheimer's disease	0.000144	0.00358	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000144	0.00357	CbGpPWpGaD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000139	0.00344	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—PPARGC1A—Alzheimer's disease	0.000137	0.0034	CbGpPWpGaD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000137	0.0034	CbGpPWpGaD
Levobupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000135	0.00335	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.000133	0.0033	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—PPARGC1A—Alzheimer's disease	0.000132	0.00328	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000131	0.00325	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—GSK3B—Alzheimer's disease	0.000127	0.00315	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—CREB1—Alzheimer's disease	0.000126	0.00313	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—LPL—Alzheimer's disease	0.000125	0.0031	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—MEF2C—Alzheimer's disease	0.000124	0.00307	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—GSK3B—Alzheimer's disease	0.000122	0.00304	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—CREB1—Alzheimer's disease	0.000121	0.00302	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—LPL—Alzheimer's disease	0.00012	0.00299	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—Alzheimer's disease	0.000119	0.00296	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—MEF2C—Alzheimer's disease	0.000119	0.00296	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000113	0.00281	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000111	0.00275	CbGpPWpGaD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000107	0.00266	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—LEP—Alzheimer's disease	0.000105	0.0026	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—MAOB—Alzheimer's disease	0.000103	0.00255	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—LEP—Alzheimer's disease	0.000101	0.0025	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	9.9e-05	0.00246	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—NOTCH1—Alzheimer's disease	9.65e-05	0.0024	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—NOTCH1—Alzheimer's disease	9.3e-05	0.00231	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—PPARG—Alzheimer's disease	9.11e-05	0.00226	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—GSK3B—Alzheimer's disease	9.05e-05	0.00225	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—CREB1—Alzheimer's disease	8.98e-05	0.00223	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—INS—Alzheimer's disease	8.93e-05	0.00222	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—PPARG—Alzheimer's disease	8.78e-05	0.00218	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—GSK3B—Alzheimer's disease	8.73e-05	0.00217	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—CREB1—Alzheimer's disease	8.66e-05	0.00215	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—INS—Alzheimer's disease	8.61e-05	0.00214	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	8.56e-05	0.00213	CbGpPWpGaD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	8.01e-05	0.00199	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	7.96e-05	0.00198	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	7.92e-05	0.00197	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—VEGFA—Alzheimer's disease	7.91e-05	0.00196	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—PTGS1—Alzheimer's disease	7.78e-05	0.00193	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—CYP2D6—Alzheimer's disease	7.63e-05	0.00189	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—VEGFA—Alzheimer's disease	7.63e-05	0.00189	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP2D6—Alzheimer's disease	7.52e-05	0.00187	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	7.15e-05	0.00178	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	6.74e-05	0.00167	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	6.6e-05	0.00164	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	6.19e-05	0.00154	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	6e-05	0.00149	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	5.88e-05	0.00146	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	5.8e-05	0.00144	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	5.78e-05	0.00144	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	5.78e-05	0.00144	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—VEGFA—Alzheimer's disease	5.64e-05	0.0014	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—IL6—Alzheimer's disease	5.47e-05	0.00136	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—VEGFA—Alzheimer's disease	5.44e-05	0.00135	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—IL6—Alzheimer's disease	5.27e-05	0.00131	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—TGFB1—Alzheimer's disease	5.18e-05	0.00129	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—TGFB1—Alzheimer's disease	4.99e-05	0.00124	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—TNF—Alzheimer's disease	4.84e-05	0.0012	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—TNF—Alzheimer's disease	4.66e-05	0.00116	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	4.41e-05	0.0011	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	4.11e-05	0.00102	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—IL6—Alzheimer's disease	3.9e-05	0.00097	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—IL6—Alzheimer's disease	3.76e-05	0.000935	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CA4—Alzheimer's disease	3.75e-05	0.000931	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	3.66e-05	0.00091	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—AKT1—Alzheimer's disease	3.6e-05	0.000895	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	3.52e-05	0.000875	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—AKT1—Alzheimer's disease	3.47e-05	0.000863	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	3.4e-05	0.000845	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	3.34e-05	0.00083	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PLD3—Alzheimer's disease	3.19e-05	0.000792	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.19e-05	0.000792	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.15e-05	0.000783	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	3.05e-05	0.000759	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.99e-05	0.000742	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	2.94e-05	0.000731	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.89e-05	0.000719	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ND1—Alzheimer's disease	2.84e-05	0.000706	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.78e-05	0.00069	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.72e-05	0.000676	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.58e-05	0.00064	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.54e-05	0.000631	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.46e-05	0.000611	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.36e-05	0.000586	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.27e-05	0.000564	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.19e-05	0.000545	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.19e-05	0.000544	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.99e-05	0.000495	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CHAT—Alzheimer's disease	1.83e-05	0.000455	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TPI1—Alzheimer's disease	1.83e-05	0.000455	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MAOB—Alzheimer's disease	1.75e-05	0.000436	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	1.69e-05	0.00042	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.67e-05	0.000415	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.65e-05	0.000411	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—A2M—Alzheimer's disease	1.63e-05	0.000405	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.45e-05	0.000361	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ACHE—Alzheimer's disease	1.42e-05	0.000353	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.41e-05	0.000351	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.41e-05	0.000351	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	1.4e-05	0.000349	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.35e-05	0.000336	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	1.33e-05	0.00033	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	1.33e-05	0.00033	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	1.3e-05	0.000324	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.3e-05	0.000324	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.26e-05	0.000313	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	1.24e-05	0.000307	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	1.17e-05	0.00029	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.14e-05	0.000284	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	1.13e-05	0.000281	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.1e-05	0.000272	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.08e-05	0.000269	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.03e-05	0.000255	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.03e-05	0.000255	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.01e-05	0.00025	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	9.75e-06	0.000242	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	9.7e-06	0.000241	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	9.54e-06	0.000237	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	9e-06	0.000224	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LPL—Alzheimer's disease	8.87e-06	0.00022	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	8.73e-06	0.000217	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	7.99e-06	0.000198	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	7.52e-06	0.000187	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	7.49e-06	0.000186	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	7.46e-06	0.000185	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOE—Alzheimer's disease	7.44e-06	0.000185	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	7.37e-06	0.000183	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LPL—Alzheimer's disease	6.85e-06	0.00017	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	6.48e-06	0.000161	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—INS—Alzheimer's disease	6.35e-06	0.000158	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	6.17e-06	0.000153	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	5.76e-06	0.000143	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOE—Alzheimer's disease	5.74e-06	0.000143	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	5.69e-06	0.000141	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	5.57e-06	0.000138	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	5.1e-06	0.000127	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	5e-06	0.000124	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—INS—Alzheimer's disease	4.9e-06	0.000122	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	4.3e-06	0.000107	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.93e-06	9.77e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	2.56e-06	6.36e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.98e-06	4.91e-05	CbGpPWpGaD
